Showing 19,661 - 19,680 results of 39,386 for search '(( significant decrease decrease ) OR ( significant ((level disease) OR (teer decrease)) ))', query time: 0.70s Refine Results
  1. 19661
  2. 19662

    Data_Sheet_3_Potential diagnostic markers and therapeutic targets for non-alcoholic fatty liver disease and ulcerative colitis based on bioinformatics analysis and machine learning... by Zheng Luo (284622)

    Published 2024
    “…Background<p>Non-alcoholic fatty liver disease (NAFLD) and ulcerative colitis (UC) are two common health issues that have gained significant global attention. …”
  3. 19663

    Data_Sheet_4_Potential diagnostic markers and therapeutic targets for non-alcoholic fatty liver disease and ulcerative colitis based on bioinformatics analysis and machine learning... by Zheng Luo (284622)

    Published 2024
    “…Background<p>Non-alcoholic fatty liver disease (NAFLD) and ulcerative colitis (UC) are two common health issues that have gained significant global attention. …”
  4. 19664

    Data_Sheet_2_Potential diagnostic markers and therapeutic targets for non-alcoholic fatty liver disease and ulcerative colitis based on bioinformatics analysis and machine learning... by Zheng Luo (284622)

    Published 2024
    “…Background<p>Non-alcoholic fatty liver disease (NAFLD) and ulcerative colitis (UC) are two common health issues that have gained significant global attention. …”
  5. 19665

    Data_Sheet_1_Potential diagnostic markers and therapeutic targets for non-alcoholic fatty liver disease and ulcerative colitis based on bioinformatics analysis and machine learning... by Zheng Luo (284622)

    Published 2024
    “…Background<p>Non-alcoholic fatty liver disease (NAFLD) and ulcerative colitis (UC) are two common health issues that have gained significant global attention. …”
  6. 19666

    Data Sheet 1_Tofacitinib extends survival in a mouse model of ALS through NK cell-independent mechanisms.docx by Lillia A. Baird (10575941)

    Published 2025
    “…Tofacitinib, an FDA-approved janus kinase (Jak) and signal transducer and activator (STAT) pathway inhibitor, reduces NK cytotoxicity and decreases overall levels in peripheral blood and may represent a potential ALS therapy. …”
  7. 19667

    Table 2_Tofacitinib extends survival in a mouse model of ALS through NK cell-independent mechanisms.xlsx by Lillia A. Baird (10575941)

    Published 2025
    “…Tofacitinib, an FDA-approved janus kinase (Jak) and signal transducer and activator (STAT) pathway inhibitor, reduces NK cytotoxicity and decreases overall levels in peripheral blood and may represent a potential ALS therapy. …”
  8. 19668

    Table 1_Tofacitinib extends survival in a mouse model of ALS through NK cell-independent mechanisms.xlsx by Lillia A. Baird (10575941)

    Published 2025
    “…Tofacitinib, an FDA-approved janus kinase (Jak) and signal transducer and activator (STAT) pathway inhibitor, reduces NK cytotoxicity and decreases overall levels in peripheral blood and may represent a potential ALS therapy. …”
  9. 19669
  10. 19670
  11. 19671

    Table 1_Global burden of urinary tract infections in older women from 1990 to 2021 with projections to 2040: a trend analysis of the Global Burden of Disease Study 2021.docx by Yongtao Hu (588631)

    Published 2025
    “…Between 1990 and 2021, we found Southern Latin America exhibited the largest regional-level increase in the ASIR, ASMR, and ASDR. At the national level, significant disparities in the burden of UTIs among older women were identified in different countries and territories.…”
  12. 19672
  13. 19673
  14. 19674
  15. 19675
  16. 19676

    Table 1_The relationship between serum 25-hydroxyvitamin D levels and dyslipidemia risk: insights from a study of elderly Chinese diabetic foot ulcer patients.xlsx by Chuyi Hong (22760396)

    Published 2025
    “…Subgroup analyses showed significant protective effects of 25(OH)D except in season-, Wagner grade-stratified groups and those with coronary heart disease, with no significant interactions.…”
  17. 19677
  18. 19678

    Supplementary file 1_Cistanche tubulosa glycosides ameliorate cognitive decline in APP/PS1 mice via modulation of gut microbiota and fatty acid metabolism: insights from multi-omic... by Rui Hou (161624)

    Published 2025
    “…</p>Results<p>GCT treatment significantly improved spatial memory and reduced the protein levels of Aβ and proinflammatory factors in APP/PS1 mice. …”
  19. 19679

    Data Sheet 1_Dynamic CT-based body composition analysis predicts surgical risk in Crohn’s disease with small bowel stenosis: a retrospective cohort study.pdf by Mengting Huang (6623627)

    Published 2025
    “…Background<p>Reliable predictors of surgical risk in Crohn’s disease (CD) with small bowel stenosis are lacking. …”
  20. 19680

    Overall study design. by Yu Wang (12152)

    Published 2025
    Subjects: